Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Acromegaly × pegvisomant × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hyperplasia 1 Fibrous Dysplasia, Polyostotic 1 Adenoma 1 Acromegaly 1

Interventions

pegvisomant 1 lanreotide 1 Solutions 1 Radiosurgery 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00017927 2008-03-04

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

National Institutes of Health Clinical Center (CC)

Phase 3 Completed

Acromegaly, Adenoma, Fibrous Dysplasia, Polyostotic, Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡